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This case report summarizes the first use of intravenous vitamin C employed as an adjunctive interventional agent in the
therapy of recurrent acute respiratory distress syndrome (ARDS). The two episodes of ARDS occurred in a young female
patient with Cronkhite-Canada syndrome, a rare, sporadically occurring, noninherited disorder that is characterized by extensive
gastrointestinal polyposis and malabsorption. Prior to the episodes of sepsis, the patient was receiving nutrition via chronic
hyperalimentation administered through a long-standing central venous catheter.The patient became recurrently septic with Gram
positive cocci which led to two instances of ARDS. This report describes the broad-based general critical care of a septic patient
with acute respiratory failure that includes fluid resuscitation, broad-spectrum antibiotics, and vasopressor support. Intravenous
vitamin C infused at 50mg per kilogram body weight every 6 hours for 96 hours was incorporated as an adjunctive agent in the
care of this patient. Vitamin C when used as a parenteral agent in high doses acts “pleiotropically” to attenuate proinflammatory
mediator expression, to improve alveolar fluid clearance, and to act as an antioxidant.
1. Introduction
For many years, intensivists have searched for some agent
which will attenuate the lung injury induced by the onset
of pathological processes which lead to acute respiratory
distress syndrome (ARDS). Thus far, following decades of
research, utilizing both preclinical research employing ani-
mal model systems and clinical trials in human subjects
with ARDS, no agent has been identified which attenuates
ARDS-induced lung injury. Currently, ARDS continues to be
associatedwith an approximately 25%mortality. Patientswho
survive ARDS often suffer long-term morbid complications
from critical care support as well as posttraumatic stress
disorder derived from protracted hospitalization and critical
care support. In this case report, we describe the first use of
intravenous vitaminC as an agent to attenuate sepsis-induced
ARDS.
2. Case Presentation
31-year-old Sudanese female with a medical history of
Cronkhite-Canada syndrome, a malabsorptive gastrointesti-
nal genetic disease, who was receiving chronic hyperali-
mentation through a long-lasting Hickman central venous
catheter, presented to the emergency department with fever
(101.7 F), myalgia, and tachycardia. The patient was nor-
motensive. Blood cultures were obtained and admission
was recommended, but the patient declined admission. PA
and lateral chest X-ray film was clear. No antibiotics were
administered at this time (Figure 1). Forty-eight hours later,
she returned to the emergency department with worsened
fever and myalgia. Blood cultures returned positive for
Gram positive cocci. The patient was admitted to acute care
medicine but soon became hypotensive and tachycardic.
She was transferred to the medical intensive care unit after
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Figure 1
Figure 2
receiving four liters of intravenous volume resuscitation
with 0.9% saline. Norepinephrine infusion was required
and vancomycin and piperacillin/tazobactam was initiated.
The patient’s central venous catheter, suspected to be the
source of the bacteremia, was promptly removed and a new
central venous catheter placed. On hospital day 2, the patient
experienced worsened dyspnea and hypoxemia that neces-
sitated noninvasive positive pressure ventilation (NIPPV).
Repeat chest imaging revealed more remarkable opacities
(Figure 2). On hospital day 3, hypoxemia and radiographic
abnormalities becamemore significant (Figure 3).Thepatient
was intubated and invasive mechanical ventilation begun
for apparent sepsis-associated acute respiratory distress syn-
drome (ARDS). Bronchoscopy performed at this time yielded
no pathogens. Low tidal volume ventilation (6 cc/kg of ideal
body weight, followed by a reduction to 4 cc/kg of ideal
body weight) with high positive end expiratory pressure was
initiated employing assist/control pressure/control ventila-
tion. Despite this approach, the patient remained profoundly
hypoxemic (PaO
2
/FiO
2
ratio, 63mmHg). Intravenous vita-
min C (50mg/kg every 6 hours) was initiated on hospital day
4. Chest imaging via AP chest X-ray film on hospital day 5
revealed significantly improved bilateral opacities (Figure 4).
Figure 3
Figure 4
PaO
2
/FiO
2
ratio improved significantly to 190mmHg. On
hospital day 7, the patient was successfully extubated.
Six weeks following initial hospitalization, the patient
re-presented to the emergency department once again with
headaches, fevers, and myalgia. The patient was hypoten-
sive on admission (62/37mmHg). Fluid resuscitation was
undertaken. Hypotension persisted and she was admitted
to medical ICU where she was ultimately intubated for
respiratory failure. Figure 5 shows the patient’s initial chest
X-ray. Despite invasive mechanical ventilation, oxygenation
deteriorated and the criteria for ARDS were again met.
Neuromuscular paralysis (cisatracurium) was required on
ventilator day 3 due to elevated peak airway pressures and
ventilator dyssynchrony. Despite this, oxygenation remained
severely depressed (PaO
2
/FiO
2
= 100). On ventilator day
4, intravenous vitamin C (50mg/kg every 6 hours) was
initiated (Figure 6). Within two days (ventilator day 6), chest
imaging dramatically improved (Figure 7) as did oxygenation
(PaO
2
/FiO
2
ratio = 316mmHg). On ventilator day 10, the
patient was weaned and was successfully extubated.
3. Discussion
We report here the application of high dose intravenous
vitamin C employed as an interventional drug treatment
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for ARDS. Very few studies in critically ill patients with
ARDS have reported the use of intravenous vitamin C. The
use of vitamin C to treat lung injury is still investigational.
Nathens et al. infused ascorbic acid at 1 gram every 8 hours
combined with oral vitamin E for 28 days in 594 surgically
critically ill patients and found a significantly lower incidence
of acute lung injury and multiple organ failure [1]. Tanaka et
al. infused ascorbic acid continuously at 66mg/kg/hour for
the first 24 hours in patients with greater than 50% surface
area burns and showed significantly reduced burn capillary
permeability [2]. A single report (published as abstract only)
of a clinical study of large intravenous doses of ascorbic acid,
and other antioxidants (tocopherol, N-acetyl-cysteine, and
selenium), in patients with established ARDS showed reduc-
tion in mortality of 50% [3]. Clinical protocols currently in
use for hospitalized septic patients fail to normalize ascorbic
acid levels. Vitamin C dosages utilized in the treatment of the
patientwe describe in this case report arose fromour previous
human studies, infusing high dose intravenous vitamin C
into critically ill patients with severe sepsis [4], and in our
preclinical studies [5–7]. Our work thus far shows vitamin C
to exert potent “pleotropic effects” when used as described
in this report. We showed that septic patients receiving high
Figure 7
dose intravenous vitamin C exhibit significant reduction in
multiple organ injury and reduced inflammatory biomarker
levels [4]. Our preclinical work in septic lung-injured animals
shows that vitamin C downregulates proinflammatory genes
that are driven by transcription factor NF-𝜅B. Furthermore,
vitamin C significantly increases alveolar fluid clearance in
septic lung-injured animals [7]. Finally, infused vitamin C’s
capability to downregulate liberated reactive oxygen and
nitrogen species appears to be critical for attenuating lung
injury [8].
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